BRIEF — Formycon And Zydus Say FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted For Review By FDA
Oct 13 (Reuters) — Formycon AG: Eqs-news: Formycon And Zydus: Fyb206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted For Review By Fda Source text:... Further company coverage: FYB.DE (Reuters.Briefs@thomsonreuters.com;)